Related Experiment Video
Updated: Jul 20, 2025

Extracellular Glucose Depletion as an Indirect Measure of Glucose Uptake in Cells and Tissues Ex Vivo
Published on: April 6, 2022
Glucose metabolism disorder: a potential accomplice of SARS-CoV-2
Yi Luan1, Ying Luan2, Hongbo He3
1Department of Translational Medicine Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Abstract:
Globally, 265,713,467 confirmed cases of SARS-CoV-2 (CoV-2), including 5,260,888 deaths, have been reported by the WHO. It is important to study the mechanism of this infectious disease. A variety of evidences show the potential association between CoV-2 and glucose metabolism. Notably, people with type 2 diabetes mellitus (T2DM) and other metabolic complications were prone to have a higher risk of developing a more severe infection course than people who were metabolically normal. The correlations between glucose metabolism and CoV-2 progression have been widely revealed. This review will discuss the association between glucose metabolism disorders and CoV-2 progression, showing the promoting effect of diabetes and other diseases related to glucose metabolism disorders on the progression of CoV-2. We will further conclude the effects of key proteins and pathways in glucose metabolism regulation on CoV-2 progression and potential interventions by targeting glucose metabolism disorders for CoV-2 treatment. Therefore, this review will provide systematic insight into the treatment of CoV-2 from the perspective of glucose metabolism.
Insights
This review highlights how diabetes and glucose metabolism disorders worsen SARS-CoV-2 (CoV-2) infection outcomes. Targeting these metabolic issues may offer new treatments for severe CoV-2 disease.
Area of Science:
- Metabolic Medicine
- Infectious Diseases
- Molecular Biology
Background:
- Over 265 million SARS-CoV-2 (CoV-2) cases and 5.2 million deaths reported globally.
- Individuals with type 2 diabetes mellitus (T2DM) face increased risk of severe CoV-2 infection.
- Established link between glucose metabolism and CoV-2 progression.
Purpose of the Study:
- To review the association between glucose metabolism disorders and CoV-2 progression.
- To elucidate the impact of diabetes on CoV-2 severity.
- To identify therapeutic targets within glucose metabolism for CoV-2 treatment.
Main Methods:
- Literature review synthesizing evidence on glucose metabolism and CoV-2.
- Analysis of key proteins and pathways regulating glucose metabolism.
- Exploration of potential interventions targeting metabolic disorders.
Main Results:
- Glucose metabolism disorders, including T2DM, promote severe CoV-2 progression.
- Specific proteins and pathways in glucose metabolism significantly influence CoV-2 outcomes.
- Targeting metabolic dysregulation presents a promising therapeutic strategy.
Conclusions:
- Dysregulated glucose metabolism exacerbates SARS-CoV-2 (CoV-2) infection.
- Interventions aimed at glucose metabolism disorders could be crucial for managing CoV-2.
- This review offers a metabolic perspective for CoV-2 treatment strategies.
More Related Videos
Related Concept Videos
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Diabetes: Symptoms, Diagnosis, and Complications
Hypoglycemia and Glucagon

